Tag: Venclextas
EHA: AbbVie, Roche cement Venclexta’s place in AML with survival win
AbbVie and Roche’s Venclexta has struggled to significantly prolong acute myeloid leukemia (AML) patients’ lives when coupled with a certain type of chemo. But...
